Use of fertility treatments in BRCA1/2 mutation carriers and risk for ovarian and breast cancer: a systematic review.

Huber, D; Seitz, S; Kast, K; Emons, G; Ortmann, O

Huber, D; Seitz, S; Kast, K; Emons, G; Ortmann, O.

Afiliación

Huber D; Department of Gynecology and Obstetrics, University Medical Center Regensburg, Regensburg, Germany.
Seitz S; Department of Gynecology and Obstetrics, University Medical Center Regensburg, Regensburg, Germany.
Kast K; Department of Gynecology and Obstetrics, Medical Faculty, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany.
Emons G; Department of Gynecology and Obstetrics, Georg August University Göttingen, University Medicine, Göttingen, Germany.
Ortmann O; Department of Gynecology and Obstetrics, University Medical Center Regensburg, Regensburg, Germany. olaf.ortmann@klinik.uni-regensburg.de.

Arch Gynecol Obstet ; 302(3): 715-720, 2020 09.

Article en En | MEDLINE | ID: mdl-32719921

Asunto(s)

Neoplasias de la Mama/genética; Preservación de la Fertilidad/métodos; Genes BRCA1/fisiología; Genes BRCA2/fisiología; Neoplasias Ováricas/genética; Estudios de Casos y Controles; Estudios de Cohortes; Femenino; Humanos; Persona de Mediana Edad; Mutación; Estudios Retrospectivos; Factores de Riesgo

Palabras clave

BRCA1; BRCA2; Breast cancer; Fertility preservation; Fertility treatment; Ovarian cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Neoplasias de la Mama / Genes BRCA1 / Genes BRCA2 / Preservación de la Fertilidad Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Female / Humans / Middle aged Idioma: En Revista: Arch Gynecol Obstet Asunto de la revista: GINECOLOGIA / OBSTETRICIA Año: 2020 Tipo del documento: Article País de afiliación: Alemania

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google